Formulation comprising histone deacetylase inhibitor exhibiting biphasic release

The present invention relates to an orally available galenics formulation of Valproic Acid or derivatives thereof exhibiting a specific bi-phasic pharmacokinetic profile optimized for maximum inhibition of histone deacetylases in a therapeutic setting. This specific galenics formulation is designed...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MAURER ALEXANDER B. DR, LENNARTZ PETER DR, FRANKE HANSHERMANN DR, HOVELMANN SASCHA DR, HENTSCH BERND DR, MARTIN ELKE DR
Format: Patent
Sprache:eng ; slv
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!